OpGen, Inc. (OPGN) Social Stream



OpGen, Inc. (OPGN): $0.57

0.03 (+4.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Opgen Inc (OPGN) Price Targets From Analysts

Use the tables below to see what analysts covering Opgen Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-11 2 $7 $4 $5.5 $0.753 630.41%
2022-03-30 1 $4 $4 $4 $0.753 431.21%

Price Target Last Issued March 30, 2022

The Trend in the Analyst Price Target


Over the past 33 weeks, OPGN's average price target has gone down $1.

OPGN reports an average of 176.21% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-15 0 7 4 5.5 2.00 175%
2021-08-05 0 7 4 5.5 2.47 122.67%
2021-12-15 2 7 4 5.5 1.22 350.82%
2022-01-11 2 4 4 4.0 1.05 280.95%
2022-03-30 1 4 4 4.0 0.78 412.82%

OPGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 120 days, OPGN's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Opgen Inc's average analyst price target is greater than 6.89% of them.
  • In the context of all US stocks, Opgen Inc's number of analysts covering the stock is higher than 9.42% of them.
  • In terms of how Opgen Inc fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 276.9% of that group.
  • OPGN has a lower variance in analysts' estimates than 25.84% of stocks in the micro market cap category.

Stocks similar to Opgen Inc in the Healthcare industry regarding analyst recommendations and price targets are MDXH, BIOC, and ANPC.

Is OPGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5414 seconds.